sfn2003

Neale JJ, Goodchild AK, Dampney RAL, Pilowsky PM (2003) Destruction of brainstem catecholamine neurons attenuates somatosympathetic reflex and responses to cholecystokinin. Neuroscience 2003 Abstracts 501.11. Society for Neuroscience, New Orleans, LA.

Summary: The integrity of the rostral ventrolateral medulla (RVLM) is essential for the expression of many sympathetic reflexes and the maintenance of vasomotor tone. The RVLM contains bulbospinal neurons, of which about half are catecholaminergic (C1). Destruction of bulbospinal C1 neurons leads to attenuation or abolition of the sympathetic baroreflex and chemoreflex, respectively. This study examines the effects of such destruction on blood pressure (BP), the somatosympathetic reflex and responses to intravenous (i.v) cholecystokinin (CCK) in urethane-anaesthetised, paralysed and ventilated Sprague-Dawley rats. Eighty percent of the spinally projecting C1 neurons in the RVLM were destroyed by bilateral microinjections of the immunotoxin, anti-DBH-saporin (12ng/100nl), into the intermediolateral cell column of the thoracic spinal cord (T1-2). Following treatment with the neurotoxin, systolic BP was measured for 3-5 weeks before testing the reflexes. No significant changes in systolic BP were observed. In the present study destruction of bulbospinal C1 neurons attenuated the baroreflex, replicating the findings of Schreihofer and Guyenet (2000, Am J Physiol 279:R729-R742). Activation of the somatosympathetic reflex by electrical stimulation of the tibial nerve normally elicits two peaks in averaged splanchnic sympathetic nerve activity. Following destruction of C1 neurons, the threshold voltage was reduced and the second peak was either markedly attenuated or abolished at two times threshold voltage. Intravenous injection of CCK (1, 10 and 100mg/kg) elicited depressor and sympathoinhibitory responses that were significantly reduced following destruction of bulbospinal C1 neurons. These results demonstrate a key role of bulbospinal C1 neurons in the somatosympathetic reflex and the sympathetic responses to i.v CCK but not in the tonic control of blood pressure.

Related Products: Anti-DBH-SAP (Cat. #IT-03)

Recabarren MP, Valdes JL, Seron-Ferre M, Torrealba F (2003) Tuberomammillary nucleus lesion decreases the anticipatory events induced by restricted feeding in rats. Neuroscience 2003 Abstracts 510.19. Society for Neuroscience, New Orleans, LA.

Summary: Our previous studies indicate that the histamine-containing neurons of the tuberomammillary nucleus (TMN) become active in anticipation to feeding time in rats under a restricted feeding schedule. To assess the role of the TMN in this anticipatory activity in rats, we lesioned the TMN bilaterally with stereotaxic injections of 50ng ORX-SAP (Advanced Targeting System, CA). We analyzed the locomotor activity, core temperature and the feeding frequency exhibited by these animals during a restricted feeding protocol, where food was available between 10:00 h and 12:00 h for at least 2 weeks. Rats were implanted in the abdominal cavity with telemetric sensors (Minimitter, OR) to measure locomotor activity and core temperature. During the whole experiment rats were maintained in individual cages and under controlled photoperiod of 12 hours light and 12 hours dark, light were on at 07:00 h. We analyzed the 3 hours preceding food arrival. We checked the extent of TMN destruction by immunostaining the brain sections with antibody against adenosine diaminase (ADA), which colocalize with histaminergic neurons in the TMN. Control rats were subjected to the same procedures except for the injection of the ORX-SAP toxin. Results: Lesion rats showed a significant decrease in the number of ADA-ir neurons in the TMN, as well as a decreased anticipatory activity under restricted feeding in comparison with control rats. Lesion rats although awake before food arrival, were less eager to feed compared to controls, as assessed by food bin approaches. Control rats were slightly more active than lesion rats during restriction. In conclusion, the functional integrity of the TMN is required for the full expression of the anticipatory events that are stimulated by a restricted feeding schedule.

Related Products: Orexin-B-SAP (Cat. #IT-20)

Hunter CL, Quintero EM, Gilstrap L, Bhat NR, Granholm AE (2003) Neuroinflammatory response to mu p75-saporin immunotoxin-induced degeneration of basal forebrain cholinergic neurons. Neuroscience 2003 Abstracts 527.15. Society for Neuroscience, New Orleans, LA.

Summary: Basal forebrain cholinergic neurons, which provide the major cholinergic innervation to the cortical regions and play a key role in the processing of information involved in cognitive processes, degenerate during both normal aging and Alzheimer’s disease. Neuroinflammation, specifically the activation of microglia, is known to affect the progression of neuronal degeneration. Activated microglia produce inflammatory mediators that have neuropathic as well as neuroprotective actions, and it has been suggested that inflammatory mediators produced by activated microglia may play a role in the decline of specific neuronal sub-types in neurodegenerative diseases. The immunotoxin mu p75-SAP has been shown to selectively destroy cholinergic neurons in the basal forebrain of mice, resulting in reduced choline acetyl-transferase activity and cognitive impairments. To characterize the inflammatory response to mu p75-SAP lesions, 3 month-old mice received icv injections of mu p75-SAP (3.6 mg) followed by treatment with an anti-inflammatory agent, minocycline (45 mg/kg i.p.), or saline. Seven days after lesioning, immunohistochemistry was used to analyze markers for cholinergic and non-cholinergic neurons and inflammation. Cholinergic lesioning resulted in a dramatic increase in CD45, a microglial marker, but no change in GFAP, an astroglial marker, in the basal forebrain region. Lesioned animals had elevated levels of phosphorylated p38, a MAP kinase protein involved in inflammatory pathways. Minocycline treatment reduced this inflammatory response. Furthermore, preliminary results suggest that animals treated with minocycline after mu p75-SAP lesioning are partially protected from cholinergic degeneration.

Related Products: mu p75-SAP (Cat. #IT-16)

Richerson GB, Nattie EE, Deneris ES, Lauder JM (2003) Serotonergic neurons and development: implications for normal brain function and human disease. Neuroscience 2003 Abstracts 329. Society for Neuroscience, New Orleans, LA.

Summary: Symposium. Serotonergic neurons have widely divergent projections to virtually all of the CNS, and are involved in a variety of brain functions. This symposium will focus on how dysfunction of 5-HT neurons during development can influence brain function throughout life. G Richerson will discuss pH chemosensitivity of 5-HT neurons, how this changes during development, and the emerging hypothesis that these neurons induce arousal, a feeling of suffocation and hyperventilation in response to increased CO2. E Nattie has used focal manipulations of the raphe in vivo, including cell specific killing with an antibody to the serotonin transporter conjugated to the toxin saporin, to show that dysfunction of 5-HT neurons may lead to a defect in physiologic regulatory processes that are important during development. E Deneris will discuss mutant mice lacking the Pet-1 ETS gene, in which the majority of CNS 5-HT neurons are missing. 25-30% of Pet-1 nulls die during the first postnatal week, which may result from abnormal respiration. Surviving adults display anxiety-like and aggressive behavior. J Lauder will discuss 5-HT as a differentiation signal in prenatal brain development and as a morphogen in craniofacial development. Effects of prenatal exposure to serotonergic drugs or neurotoxins on postnatal outcome will be described. The speakers will introduce new hypotheses about how dysregulation of 5-HT neurons and 5-HT receptors during development may lead to a variety of brain disorders such as SIDS, migraine, autism, panic attacks and anxiety.

Related Products: Anti-SERT-SAP (Cat. #IT-23)

Cooper-Kuhn CM, Winkler J, Kuhn H (2003) Altered neurogenesis after cholinergic forebrain lesion in the adult rat. Neuroscience 2003 Abstracts 348.9. Society for Neuroscience, New Orleans, LA.

Summary: Adult hippocampal neurogenesis has been shown to be functionally connected to learning and memory and at the same time to be regulated by a multitude of extracellular cues, including hormones, growth factors, and neurotransmitters. The cholinergic forebrain system is one of the key transmitter systems for learning and memory. Within the hippocampus and olfactory bulb, two regions of adult neurogenesis, cholinergic innervation is quite extensive. This experiment aims at defining the role of cholinergic input during adult neurogenesis by using an immunotoxic lesion approach. The immunotoxin 192IgG-saporin was infused into the lateral ventricle of adult rats to selectively lesion the cholinergic neurons of the cholinergic basal forebrain (CBF), which project to the dentate gyrus and the olfactory bulb. Five weeks after lesion the rate of neurogenesis declined significantly in the dentate gyrus and olfactory bulb granule cell layers, whereas the generation of neurons in the periglomerular region of the olfactory bulb was unaffected. The number of apoptotic cells increased specifically in the progenitor region of the dentate gyrus as well as in the periglomerular layer of the olfactory bulb. Therefore, one of the possible mechanisms by which acetylcholine could promote neurogenesis is by increasing the survival of progenitor and immature neurons. Neurotransmitters can alter the microenvironment of neural progenitor cells, whether directly or indirectly, and these changes lead to significant alterations in neurogenesis. In principle, the data suggest that acetylcholine is stimulatory to adult hippocampal neurogenesis, since neurotoxin lesions specific to this neurotransmitter system lead to a reduced number of new neurons.

Related Products: 192-IgG-SAP (Cat. #IT-01)

Wiley RG, Miller SA, Kline IV RH (2003) Selective destruction of MOR expressing dorsal horn neurons using intrathecal dermorphin-saporin. Neuroscience 2003 Abstracts 174.15. Society for Neuroscience, New Orleans, LA.

Summary: Evidence suggests that the mu opiate receptor (MOR) is key to the analgesic action of morphine. In the present study, we sought to determine if a disulfide conjugate of the mu opioid peptide, dermorphin, to the ribosome-inactivating protein, saporin, (derm-sap) would destroy neurons expressing MOR in the substantia gelatinosa (SG) of the spinal cord. Derm-sap was injected into the lumbar subarachnoid space of anesthetized adult, male Sprague-Dawley rats using a catheter inserted through the atlanto-occipital membrane and passed 8 cm caudally. The catheter was removed 15 minutes after toxin injection. Rats were sacrificed after 2 weeks, and 40 um transverse frozen sections of the L4 spinal segment were processed for immunohistochemical demonstration of MOR, NeuN, calbindin D28k, parvalbumin, NK-1R and for Nissl staining. In control rats, beta-funaltrexamine was injected just before derm-sap or derm-sap was pre-treated to reduce the disulfide bond which dissociates the toxin and neuropeptide. MOR staining in the SG was evaluated using quantitative densitometry. Initial experiments revealed a dose-related decrease in MOR staining in the dorsal horn without effect on dorsal root ganglia at doses up to 1000 ng. The maximally tolerated dose of derm-sap (500 ng) selectively decreased MOR staining by 54% as did multilevel lumbar dorsal rhizotomy. Combining 500 ng of derm-sap and multilevel rhizotomy produced 92% loss of MOR staining in the SG. Based on analysis of non-co-localized markers and control experiments, we interpret the results to indicate that intrathecal derm-sap selectively destroys MOR-expressing neurons in the SG without toxicity to primary afferents. This lesion will be useful in analysis of opioid mechanisms in the dorsal horn.

Related Products: Dermorphin-SAP / MOR-SAP (Cat. #IT-12)

Kline IV RH, Wiley RG (2003) SSP-saporin decreases formalin induced c-Fos expression throughout the dorsal horn. Neuroscience 2003 Abstracts 174.7. Society for Neuroscience, New Orleans, LA.

Summary: Substance P (SP) antagonists and SP-saporin have been shown to decrease phase II of the formalin test suggesting an important role for SP in this model of persistent pain. SP antagonists also decrease formalin induced c-fos expression in dorsal horn neurons. A congener of SP-sap that is more stable and has higher affinity for NK-1R, SSP-sap (Sar9Met(02)11-substance P-saporin) has been studied by injection into the striatum and hippocampus where it was more potent and specific than SP-sap. In the present study, this selective and more potent toxin was used to determine the effects of destroying dorsal horn NK-1R on behavior and c-fos induction after intraplantar formalin. Twelve Sprague Dawley male rats were injected intrathecally with 100ng SSP-sap or PBS. After 2 weeks survival, rats underwent hindpaw formalin injections and behavioral scoring, and then were sacrificed after 3 hours and the lumbar spinal cords processed for immunohistochemical demonstration of NK-1R and c-fos. There were significant correlations between the loss of superficial laminae NK-1R neurons, decreased formalin behavior and dorsal horn c-fos expression. Therefore lumbar i.t. SSP-sap 1) decreased NK-1R cells in laminae I but not in the deeper laminae 2) decreased phase II formalin behavior 3) decreased c-fos in both the superficial and deep laminae. Since c-fos expression in the deeper laminae was decreased and NK-1R was spared in these laminae, we conclude that a lesion affecting only laminae I NK-1R lesion alters activation of neurons throughout the dorsal horn suggesting a key role for the missing neurons in the transfer of nociceptive inputs to deeper laminae.

Related Products: SSP-SAP (Cat. #IT-11)

Xie Y, Vanderah TW, Ossipov MH, Lai J, Porreca F (2003) A single rostral ventromedial medulla (RVM) treatment with cholecystokinin-saporin (CCK-sap) prevents the development of opioid-induced paradoxical pain and spinal morphine antinociceptive tolerance. Neuroscience 2003 Abstracts 177.4. Society for Neuroscience, New Orleans, LA.

Summary: Sustained morphine elicits tactile and thermal hypersensitivity (opioid-induced paradoxical pain) and antinociceptive tolerance which are mediated through the time-dependent activation of descending facilitation from the RVM. With morphine exposure, CCK expression and/or release may be altered to activate pain facilitatory neurons of the RVM, manifesting as diminished spinal morphine antinociception (antinociceptive tolerance). To explore a possible role of RVM CCK in morphine-induced paradoxical pain and tolerance, CCK-SAP conjugate was used to selectively lesioned RVM neurons expressing CCK receptors. Male S-D rats received a single RVM injection of CCK, SAP or CCK-SAP. Behavioral responses to tactile (von Frey) and thermal (radiant heat) stimuli were normal 3,7,14 and 28 days after injection. RVM CCK microinjection produced tactile and thermal hypersensitivity in uninjured rats 28 days after receiving RVM CCK or SAP, but not in those receiving CCK-SAP, suggesting the probable loss of RVM CCK receptor-expressing cells. 28 days after RVM CCK, SAP or CCK-SAP injections, rats were implanted with placebo or morphine pellets. Morphine pelleted rats pretreated with RVM CCK or SAP developed tactile and thermal hypersensitivity and spinal antinociceptive tolerance. In contrast, animals pretreated with RVM CCK-SAP did not show morphine induced tactile or thermal hypersensitivity and antinociceptive tolerance was not present. Moreover, CCK-SAP, but not CCK or SAP, pretreatment significantly attenuated the antinociceptive effect of RVM morphine. This suggests that RVM CCK activates tonic descending facilitation driving morphine-induced abnormal pain and spinal antinociceptive tolerance. Moreover, these results suggest the possibility that CCK and opioid receptors may colocalize on some RVM neurons which may act to facilitate pain transmission.

Related Products: CCK-SAP (Cat. #IT-31)

Harasawa I, Lai J, Porreca F, Fields HL, Meng ID (2003) Selective elimination of mu-opioid receptor expressing neurons in the rostral ventromedial medulla (RVM) does not affect periaqueductal gray (pag) stimulation-produced analgesia. Neuroscience 2003 Abstracts 177.5. Society for Neuroscience, New Orleans, LA.

Summary: PAG stimulation produces antinociception at spinal levels by modulating RVM neuronal activity. Microinjection of saporin conjugated with the mu-opioid receptor agonist dermorphin (DERM-SAP) into the RVM selectively eliminates MOR expressing neurons and diminishes neuropathic pain symptoms (Porreca et al., 2001). The aim of the present study was to determine whether MOR expressing neurons in the RVM are required for PAG stimulation produced analgesia (PAG/SPA). The minimum electrical current required to inhibit the tail flick response was compared in barbiturate-anesthetized rats given a single RVM injection of SAP or DERM-SAP 3-4 weeks prior to testing. Thresholds in SAP and DERM-SAP treated rats were not different. Furthermore, microinjection of the glutamate receptor antagonist kynurenic acid (10 mM, 800 nl) into the RVM disrupted PAG/SPA in both SAP and DERM-SAP treated rats. These results indicate that 1) mu-receptor expressing neurons in the RVM are not necessary for PAG/SPA, and 2) excitatory amino acid transmission in the RVM is critical for PAG/SPA. In additional experiments, inhibition of neurotransmitter release in the RVM by the microinjection of cobalt chloride (CoCl2, 100 mM, 800 nl), produced significant antinociception only in DERM-SAP treated rats. This finding suggests that DERM-SAP injections result in increased tonic inhibition of RVM neurons and that CoCl2 disinhibits these neurons to produce antinociception. Tonic inhibition of off-cells would account for our failure to find off-cells in DERM-SAP treated rats.

Related Products: Dermorphin-SAP / MOR-SAP (Cat. #IT-12)

Leung LS, Shen B, Ma J, Rajakumar N (2003) Cholinergic activity enhances hippocampal CA1 long-term potentiation during walking in rats. Neuroscience 2003 Abstracts 255.5. Society for Neuroscience, New Orleans, LA.

Summary: Long-term potentiation (LTP) at the basal dendrites of CA1 pyramidal cells was induced by a single 200-Hz stimulation train (0.5-1 sec duration) in freely behaving rats during one of four behavioral states – awake-immobility (IMM), walking, slow-wave sleep (SWS) and rapid-eye-movement sleep (REMS). Field excitatory postsynaptic potentials (fEPSPs) generated by basal dendritic excitation of CA1 were recorded before and up to 20 hours after the tetanus. Following a tetanus during any behavioral state, basal dendritic LTP was > 170% of the baseline for the first 30 min after the tetanus and decayed to ~125% at 20 hours after. LTP induced during walking was significantly larger than that induced during IMM, SWS or REMS. LTP induced during IMM, SWS and REMS was not significantly different from each other. To test the hypothesis that septohippocampal cholinergic activity enhanced LTP during walking than during immobility, rats were either pretreated with muscarinic cholinergic antagonist scopolamine (5 mg/kg i.p.) or given selective cholinotoxin IgG192-saporin in the medial septum. Pretreatment with scopolamine decreased the LTP induced during walking but did not affect that induced during IMM, such that the difference between LTP induced during walking and IMM was abolished. In IgG192-saporin injected rats, there was no difference in the LTP induced during walking and during IMM, and scopolamine did not reduce the LTP induced during walking. In contrast, sham-lesioned rats, like other control rats, showed larger LTP induced during walking than during IMM, and LTP induced during walking was attenuated by scopolamine. This appears to be the first demonstration of an enhancement of hippocampal LTP by physiologically activated septal cholinergic inputs. LTP of the CA3 to CA1 synapses may serve important behavioral functions.

Related Products: 192-IgG-SAP (Cat. #IT-01)